19.2 ± 7.6 G2: 19.0 ± 7.3 Ordinary group hr/week G1: 6.1 ± 7.9 G2: 10.0 ± 7.7 C-90 Table C-1. Evidence table, continued Study Description Intervention Inclusion/ Exclusion Criteria/ Population Baseline Measures Outcomes Author: Kasari et al., 2012 42 , 43 Country: US Intervention setting: Clinic Enrollment period: NR Funding: NIH grant Design: RCT *Note: see data from earlier studies 44 , 45 reporting on this population in 2011 AHRQ review 9 Intervention: Joint attention intervention: Goal to increase child’s joint attention initiations during novel play routines. Symbolic play intervention to increase child’s level and frequency of play acts according to play scale adapted from Lifter. Treatment sessions held every day for 5-6 weeks. Control group received standard treatment (ABA) Assessments: Early Language Communication Scale (ESCS); Mullen Scales of Early Learning; Reynell Developmental Language Scales Groups: G1: joint attention intervention G2: symbolic play G3: control Provider: see Kasari et al 2006 Treatment manual followed: Yes Inclusion criteria: • Diagnosis of autism on the ADI-R and ADOS • Age < 5 years old • Accessible for follow- up Exclusion criteria: • Seizures • Additional medical diagnoses (e.g., genetic syndromes) • Geographically inaccessible for follow- up visits • Did not plan to stay in the early intervention program for at least 4 weeks Age, mean/mos ± SD: G1: 43.05 ± 6.863 G2: 41.41 ± 6.491 G3: 41.31 ± 4.542 Mental age, mean/ mos ± SD: G1: 26.29± 8.713 G2: 26.59 ± 7.550 G3: 22.05 ± 9.532 Sex: M, n (%): G1: 15 (75) G2: 11 (69) G3: 14 (87.5) Joint attention and shared positive effect, mean ± SD: G1: 3.25± 5.37 G2: 3.25 ± 4.38 G3: 4.50 ± 6.57 Joint attention and shared positive effect and utterance (s) , mean ± SD: G1: 1.05± 2.44 G2: 1.56 ± 4.00 G3: 2.50 ± 4.56 At 6 month follow-up Joint attention and shared positive effect, mean ± SD: G1: 6.15± 5.72 G2: 7.91 ± 3.06 G3: 3.06 ± 4.39 Joint attention and shared positive effect and utterance, mean ± SD: G1: 4.10± 4.64 G2: 3.19 ± 3.58 G3: 1.75 ± 3.38 At 12 month follow-up Joint attention and shared positive effect, mean ± SD: G1: 7.65± 6.80 G2: 9.44 ± 3.88 G3: 3.88 ± 5.32 Joint attention and shared positive effect and utterance (s) , mean ± SD: G1: 5.30± 5.68 G2: 5.75 ± 7.02 G3: 1.56 ± 3.10 At 5 years follow-up (n=40/58): Cognitive and language ability: >30 Months: C-91 Defined protocol followed: Yes Measure of treatment fidelity reported: Yes Co-interventions held stable during treatment: NR Concomitant therapies, n (%): NR N at enrollment: G1: 20 G2: 21 G3: 17 N at follow-up: G1: 20 G2: 16 G3: 16 At 5 years follow-up: G1: 15 G2: 14 G3: 11 F, n (%): G1: 5 (25) G2: 5 (31) G3: 2 (12.5) Race/ethnicity, n (%): White G1: 16 (80) G2: 12 (75) G3: 9 (56.3) Minority G1: 4 (20) G2: 4 (25) G3: 7 (43.7) SES: Maternal education, n (%): High school G1: